Cargando…

A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area

BACKGROUND: In 2000/2001, the Australian Defense Forces (ADF), in collaboration with SmithKline Beecham and the United States Army, conducted a field trial to evaluate the safety, tolerability and efficacy of tafenoquine and mefloquine/primaquine for the prophylaxis of malaria amongst non-immune Aus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dow, Geoffrey S, McCarthy, William F, Reid, Mark, Smith, Bryan, Tang, Douglas, Shanks, G Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942710/ https://www.ncbi.nlm.nih.gov/pubmed/24502679 http://dx.doi.org/10.1186/1475-2875-13-49

Ejemplares similares

Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
por: Dow, Geoffrey S., et al.
Publicado: (2015)

Mefloquine for preventing malaria during travel to endemic areas
por: Tickell‐Painter, Maya, et al.
Publicado: (2017)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
por: Birrell, Geoffrey W., et al.
Publicado: (2022)

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)
por: Dow, Geoffrey, et al.
Publicado: (2017)

Severe Neuropsychiatric Reaction in a Deployed Military Member after Prophylactic Mefloquine
por: Peterson, Alan L., et al.
Publicado: (2011)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Tafenoquine succinate for malaria prevention
Publicado: (2019)

Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas
por: Greenwood, Brian
Publicado: (2010)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Deployment of Early Diagnosis and Mefloquine- Artesunate Treatment of Falciparum Malaria in Thailand: The Tak Malaria Initiative
por: Carrara, Verena Ilona, et al.
Publicado: (2006)

Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2009)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
por: Baird, J Kevin
Publicado: (2018)

Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections
por: Li, Qigui, et al.
Publicado: (2014)

Malaria Prevention, Mefloquine Neurotoxicity, Neuropsychiatric Illness, and Risk-Benefit Analysis in the Australian Defence Force
por: McCarthy, Stuart
Publicado: (2015)

Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
por: Barber, Bridget E, et al.
Publicado: (2023)

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
por: Rajapakse, Senaka, et al.
Publicado: (2015)

Treatment of Suspected Hyper-Reactive Malarial Splenomegaly (HMS) in Pregnancy with Mefloquine
por: Jaroensuk, Juthamas, et al.
Publicado: (2014)

Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria
por: Congpuong, Kanungnit, et al.
Publicado: (2010)

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
por: Marcsisin, Sean R, et al.
Publicado: (2014)

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Llanos-Cuentas, A., et al.
Publicado: (2019)

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
por: Lacerda, M.V.G., et al.
Publicado: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
por: Sharma, Jatin, et al.
Publicado: (2021)

Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
por: Lundström-Stadelmann, Britta, et al.
Publicado: (2020)

Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018)

Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
por: Gutman, Julie, et al.
Publicado: (2009)

Stated preferences for anti-malarial drug characteristics in Zomba, a malaria endemic area of Malawi
por: Medina-Lara, Antonieta, et al.
Publicado: (2014)

521. A phase II, double blind, placebo-controlled, randomized evaluation of the safety and efficacy of tafenoquine in patients with mild-moderate COVID-19 disease
por: Dow, Geoffrey
Publicado: (2023)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
por: Baird, J Kevin
Publicado: (2021)

Mefloquine as a prophylaxis for malaria needs to be revisited
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan
por: Nevin, Remington L, et al.
Publicado: (2008)

Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach
por: Antao, Tiago, et al.
Publicado: (2012)

Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023)

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta)
por: Dow, Geoffrey S, et al.
Publicado: (2011)

Tafenoquine: a toxicity overview
por: Chu, Cindy S., et al.
Publicado: (2021)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria — United States, 2019
por: Haston, Julia C., et al.
Publicado: (2019)

Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
por: Suh, Jiyeon, et al.
Publicado: (2022)

Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines
por: Berman, Jonathan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nkuod3k14lelddsmepkde2bg81